Skip to main content
Mijn bibliotheek
Ga naar:
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
BSL Shop
Inloggen

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Erasmus MC heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

» Andere revante producten voor Erasmus MC studenten en medewerkers.

Registreer

Om ook buiten de locaties van Erasmus MC, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van Erasmus MC.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Journal of Autism and Developmental Disorders
Gepubliceerd in:

01-07-2008 | Original Paper

Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study

Auteurs: Marli A. Robertson, David L. Sigalet, Jens J. Holst, Jon B. Meddings, Julie Wood, Keith A. Sharkey

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 6/2008

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

We measured small intestinal permeability using a lactulose:mannitol sugar permeability test in a group of children with autism, with current or previous gastrointestinal complaints. Secondly, we examined whether children with autism had an abnormal glucagon-like peptide-2 (GLP-2) response to feeding. Results were compared with sibling controls and children without developmental disabilities. We enrolled 14 children with autism, 7 developmentally normal siblings of these children and 8 healthy, developmentally normal, unrelated children. Our study did not detect differences in these measures of gastrointestinal function in a group of children with autism.
vorige artikel Psychiatric Hospitalization Among Children with Autism Spectrum Disorders
volgende artikel Emotional Modulation of Perception in Asperger’s Syndrome
Literatuur
Ahearn, W. H., Castine, T., Nault, K., & Green, G. (2001). An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. Journal of Autism and Developmental Disorders, 31(5), 505–511.PubMedCrossRef
Blaxill, M. F. (2004). What’s going on? The question of time trends in autism. Public Health Reports, 119(6), 536–551.PubMedCrossRef
Breslin, N. P., Nash, C., Hilsden, R. J., Hershfield, N. B., Price, L. M., Meddings, J. B., & Sutherland, L. R. (2001). Intestinal permeability is increased in a proportion of spouses of patients with Crohn’s disease. The American Journal of Gastroenterology, 96(10), 2934–2938.PubMedCrossRef
Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. The American Journal of Psychiatry, 162(6), 1133–1141.PubMedCrossRef
Charman, T. (2002). The prevalence of autism spectrum disorders. Recent evidence and future challenges. European Child & Adolescent Psychiatry, 11(6), 249–256.CrossRef
D’Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., & Giardini, O. (1996). Abnormal intestinal permeability in children with autism. Acta Paediatrica, 85(9), 1076–1079.PubMedCrossRef
Drucker, D. J. (2005). Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nature Clinical Practice Endocrinology & Metabolism, 1(1), 22–31.CrossRef
Erickson, C. A., Stigler, K. A., Corkins, M. R., Posey, D. J., Fitzgrald, J. F., & McDougle, C. J. (2005). Gastrointestinal factors in autistic disorder: A critical review. Journal of Autism and Developmental Disorders, 35(6), 713–727.PubMedCrossRef
Estall, J. L., & Drucker, D. J. (2006). Glucagon-like Peptide-2. Annual Review of Nutrition, 26, 391–411.PubMedCrossRef
Field, D., Garland, M., & Williams, K. (2003). Correlates of specific childhood feeding problems. Journal of Paediatrics and Child Health, 39(4), 299–304.PubMedCrossRef
Furlano, R. I., Anthony, A., Day, R., Brown, A., & McGarvey, L. et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138(3), 366–372.PubMedCrossRef
Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. The Journal of Pediatrics 135(5), 559–563.PubMedCrossRef
Horvath, K., Zielke, R. H., Collins, R. M., Rabsztyn, A., Medeiros, L. A., & Perman, J. (2000). Secretin improves intestinal permeability in autistic children. Journal of Pediatric Gastroenterology Nutrition, 31, S31.
James, M. W., & Scott, B. B. (2000). Endomysial antibody in the diagnosis and management of coeliac disease. Postgraduate Medical Journal, 76(898), 466–468.PubMedCrossRef
Kuddo, T., & Nelson, K. B. (2003). How common are gastrointestinal disorders in children. Current Opinion in Pediatrics, 15, 339–343.PubMedCrossRef
Liu, Z., & Neu, J. (2005). Tight junctions, leaky intestines, and pediatric diseases. Acta Pediatrica., 94(4), 386–393.CrossRef
Marsilio, R., D’Antiga, L., Zancan, L., Dussini, N., & Zacchello, F. (1998) Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clinical Chemistry, 44, 1685–1691.PubMed
Martin, G. R., Wallace, L. E., & Sigalet, D. L. (2004). Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. American Journal of Physiology. Gastrointestinal and Liver Physiology, 286(6), G964–G972.PubMedCrossRef
Martin, G. R., Beck, P. L., & Sigalet, D. L. (2006). Gut hormones, and short bowel syndrome: The enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World Journal of Gastroenterology, 12(26), 4117–4129.PubMed
May, G. R., Sutherland, L. R., & Meddings, J. B. (1993). Is small intestinal permeability really increased in relatives of patients with Crohn’s disease? Gastroenterology, 104(6), 1627–1632.PubMed
Meddings, J. B., Sutherland, L. R., & May, G. R. (1994). Intestinal permeability in patients with Crohn’s disease. Gut, 35(11), 1675–1676.PubMedCrossRef
Meddings, J. B. (1997). Review article: Intestinal permeability in Crohn’s disease. Alimentary Pharmacology & Therapeutics, 11(Suppl 3), 47–53 (discussion 53–56).
Molloy, C. A., & Manning-Courtney, P (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7(2), 165–171.PubMedCrossRef
Murphy, M. S., Eastham, E. J., Nelson, R., Pearson, A. D. J., & Laker, M. F. (1989) Intestinal permeability in Crohn’s Disease. Archives of Disease in Childhood, 64, 321–325.PubMedCrossRef
Raiten, D. J., & Massaro, T. (1986). Perspectives on the nutritional ecology of autistic children. Journal of Autism and Developmental Disorders, 16(2), 133–143.PubMedCrossRef
Rice, C., (2007) Prevalence of autism spectrum disorders–Autism and developmental disabilities monitoring network, 14 Sites, United States, 2002. MMWR Surveillance Summaries, 56 (SS01); 12–28.
Shattock, P., & Whiteley, P. (2002). Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets, 6(2), 175–183.PubMedCrossRef
Sigalet, D. L., Martin, G., Meddings, J., Hartman, B., & Holst, J. J. (2004). GLP-2 levels in infants with intestinal dysfunction. Pediatric Research, 56(3), 371–376.PubMedCrossRef
Sigalet, D. L., Bawazir, O., Martin, G. R., Wallace, L. E., Zaharko, G., Miller, A., & Zubaidi, A. (2006). Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Digestive Diseases and Sciences, 51(9), 1557–1566.PubMedCrossRef
Topstad, D., Martin, G., & Sigalet, D. (2001). Systemic GLP-2 levels do not limit adaptation after distal intestinal resection. Journal of Pediatric Surgery, 36(5), 750–754.PubMedCrossRef
Torrente, F., Ashwood, P., Day, R., Machado, N., & Furlano, R. I. et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4), 375–382.PubMedCrossRef
Valicenti-McDermott, M., McVicar, A., Rapin, I., Wershil, B. K., Cohen, H., & Shinnar, S., (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental and Behavioral Pediatrics, 27, S128–S136.PubMedCrossRef
Van Elburg, R. M., Uil, J. J., Mulder, C. J., & Heymans, H. S. (1993). Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut, 34, 354–357.PubMedCrossRef
Van Elburg, R. M., Uil, J. J., Kokke, F. T., Mulder, A. M., van der Broek, W. G., Mulder, C. J., & Heymans, H. S. (1995). Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. Journal of Pediatric Gastroenterology Nutrition, 20, 184–188.CrossRef
Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., & Casson, D. M., et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637–641.PubMedCrossRef
Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., & Montgomery, S. M. et al. (2000). Enterocolitis in children with developmental disorders. The American Journal of Gastroenterology, 95(9), 2285–2295.PubMedCrossRef
Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., & O’Leary, J. J. et al. (2002). Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacology & Therapeutics, 16(4), 663–674.CrossRef
Wakefield A. J., Ashwood P., Limb K., & Anthony, A. (2005). The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. European Journal of Gastroenterology & Hepatology, 17(8), 827–836.CrossRef
Metagegevens
Titel
Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study
Auteurs
Marli A. Robertson
David L. Sigalet
Jens J. Holst
Jon B. Meddings
Julie Wood
Keith A. Sharkey
Publicatiedatum
01-07-2008
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 6/2008
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-007-0482-1

Andere artikelen Uitgave 6/2008

Psychiatric Hospitalization Among Children with Autism Spectrum Disorders

  • Original Paper

JADD Announcements for July 2008

  • Announcements

Brief Report: Cognitive Flexibility and Focused Attention in Children and Adolescents with Asperger Syndrome or High-Functioning Autism as Measured on the Computerized Version of the Wisconsin Card Sorting Test

  • Brief Report

Screening for Autism in Young Children with Developmental Delay: An Evaluation of the Developmental Behaviour Checklist: Early Screen

  • Original Paper

Use of Home Videotapes to Confirm Parental Reports of Regression in Autism

  • Original Paper

Head Circumference as an Early Predictor of Autism Symptoms in Younger Siblings of Children with Autism Spectrum Disorder

  • Original Paper